Evaluating nerve damage after breast cancer treatment
Part of Cancer, Skin clinical trials.
This study is for breast cancer survivors who have finished treatment to look more closely at chemotherapy-related nerve damage. It aims to better understand and evaluate these symptoms to improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer.
- You received chemotherapy with taxanes (a common chemo drug) and then had radiation therapy after that.
- You have no or only mild nerve-related symptoms like numbness or tingling in your hands or feet.
- You are female and at least 18 years old.
- You do not have certain skin conditions on your lower legs or feet, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.
This trial tests a non-invasive brain stimulation method to help reduce nerve pain caused by chemotherapy in breast cancer patients. It also uses brain scans to see how the treatment works.
This study looks at tiny particles in your blood to understand and potentially predict nerve damage caused by certain chemotherapy drugs. Researchers will monitor you before, during, and after your cancer treatment to see if these particles can help warn doctors about this common side effect.
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
This study tests a decision aid tool that helps people with breast cancer and nerve-related side effects from chemotherapy (like numbness or tingling) make better choices about their treatment. If you're on your third round of taxane chemo and have these symptoms, this tool may help you talk with your doctor.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.